Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $15,425 - $17,768
229 Added 2.67%
8,807 $645,000
Q4 2023

Feb 09, 2024

BUY
$64.27 - $69.9 $123,655 - $134,487
1,924 Added 28.91%
8,578 $596,000
Q3 2023

Nov 13, 2023

SELL
$61.9 - $72.77 $680 - $800
-11 Reduced 0.17%
6,654 $444,000
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $33,390 - $39,506
626 Added 10.37%
6,665 $420,000
Q1 2023

May 11, 2023

SELL
$51.63 - $56.93 $19,567 - $21,576
-379 Reduced 5.91%
6,039 $343,000
Q4 2022

Jan 31, 2023

BUY
$51.15 - $57.45 $53,298 - $59,862
1,042 Added 19.38%
6,418 $332,000
Q3 2022

Oct 26, 2022

SELL
$49.9 - $57.32 $96,207 - $110,512
-1,928 Reduced 26.4%
5,376 $281,000
Q2 2022

Oct 26, 2022

BUY
$49.62 - $58.13 $69,864 - $81,847
1,408 Added 23.88%
7,304 $405,000
Q2 2022

Aug 15, 2022

BUY
$49.62 - $58.13 $362,424 - $424,581
7,304 New
7,304 $405,000
Q1 2022

Oct 26, 2022

SELL
$48.27 - $65.25 $67,964 - $91,872
-1,408 Reduced 19.28%
5,896 $329,000
Q3 2021

Nov 15, 2021

SELL
$60.19 - $75.29 $189,237 - $236,711
-3,144 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $195,305 - $233,284
3,144 New
3,144 $231,000
Q3 2020

Nov 02, 2020

SELL
$51.39 - $72.41 $93,940 - $132,365
-1,828 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$39.55 - $54.65 $72,297 - $99,900
1,828 New
1,828 $97,000
Q4 2019

Sep 02, 2020

SELL
$36.66 - $41.78 $24,122 - $27,491
-658 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$34.82 - $39.26 $4,073 - $4,593
117 Added 21.63%
658 $25,000
Q2 2019

Aug 14, 2019

BUY
$36.05 - $42.76 $4,289 - $5,088
119 Added 28.2%
541 $20,000
Q1 2019

May 16, 2019

BUY
$35.77 - $40.57 $8,692 - $9,858
243 Added 135.75%
422 $17,000
Q3 2018

Nov 14, 2018

BUY
$29.25 - $36.73 $5,235 - $6,574
179 New
179 $6,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.28B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.